Biochemical recurrent ovarian cancer: CA 125 elevation without symptoms or clinical evidence of disease. What is the optimal management?

Emily Berry*, Jean A. Hurteau

*Corresponding author for this work

Research output: Contribution to journal › Editorial › peer-review

Fingerprint

Dive into the research topics of 'Biochemical recurrent ovarian cancer: CA 125 elevation without symptoms or clinical evidence of disease. What is the optimal management?'. Together they form a unique fingerprint.